Egypt Pharmaceutical Companies Require $1 Billion for Essential Raw Materials
Wednesday, 2 October 2024, 04:18
Raw Material Needs in Egypt's Pharmaceutical Sector
Egypt's pharmaceutical companies are currently confronting a significant challenge regarding necessary raw materials. They estimate that to sustain production, an additional $1 billion is essential by the end of this year.
Current Financial Overview
- As of September 2024, Egyptian pharmaceutical factories have received about $2 billion in foreign currency.
- The ongoing situation emphasizes the urgency of securing financial resources to ensure production continuity.
Importance of Raw Materials
Meeting the raw material demand is vital for maintaining healthcare quality and access in Egypt.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.